Search clinical trials for: FF-10501-01

Total 820 results

Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome

Japan
Johnson & Johnson K.K. Medical Company

Completed

Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)

Acute Ischemic Stroke

Japan
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

A Study of TFX05-01 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Radboud University Medical Center
CATO-SMS

Recruiting

Dose Escalation Study of Immunomodulatory Nanoparticles (PRECIOUS-01)

Advanced Solid Tumor

Netherlands
Joanne Kurtzberg, MD
The Marcus Foundation

Recruiting

UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells (DUOC-01)

Mucopolysaccharidosis II | Brain Diseases, Metabolic, Inborn | Adrenoleukodystrophy | Batten Disease | Leukodystrophy, Metachromatic | Leukodystrophy, Globoid Cell | Alpha-Mannosidosis | Tay-Sachs Disease | Pelizaeus-Merzbacher Disease | Sandhoff Disease | Neimann Pick Disease | Sanfilippo Mucopolysaccharidoses

United States
SQ Innovation, Inc.
EB Medical Research; Quartesian

Completed

A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers (G3P-01-01)

Gastrointestinal Discomfort | Performance Status

Netherlands
Alexander Kolevzon

Completed

AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy

Epilepsy | Phelan-McDermid Syndrome

United States
Personalized Stem Cells, Inc.

Unknown

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Knee Osteoarthritis

United States
Ixchelsis Limited

Completed

Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men

Healthy Participants

United Kingdom
Organogenesis

Terminated

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Wounds

Canada
Afexa Life Sciences Inc

Completed

LIP-01 in Hypercholesterolemia

Hypercholesterolemia

Canada, United States
Vedic Lifesciences Pvt. Ltd.

Completed

A Study to Evaluate the Efficacy of E-PR-01 on Musculoskeletal Health in Physically Active Individuals

Joint Pain

India
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder

Insomnia Disorder

China
GlaxoSmithKline

Completed

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

Asthma

United Kingdom, Germany, New Zealand
Cochlear
Avania

Completed

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

Hearing Impairment, Sensorineural

Australia
Hokkaido University Hospital
Japan Agency for Medical Research and Development

Recruiting

Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage (RAINBOW-Hx)

Intracerebral Hemorrhage

Japan
Valerio Therapeutics

Recruiting

A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

Breast Cancer | Prostate Cancer | Advanced or Metastatic Solid Tumors | Recurrent Ovarian Cancer

United States
Fundació Sant Joan de Déu

Active, not recruiting

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma (RTB)

Retinoblastoma, Recurrent

Spain
Institute of Hematology & Blood Diseases Hospital...
EdiGene Inc.; The Affiliated Hospital Of Guizhou Medical University; Zunyi Medical...

Active, not recruiting

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

Transfusion Dependent Beta-Thalassaemia

China
New Epsilon Innovation Limited

Active, not recruiting

An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

Advanced Solid Tumor | Relapsed AML | Refractory AML

Hong Kong
University of Virginia

Terminated

Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

United States
Washington University School of Medicine

Completed

A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors

Solid Tumors

United States
Resistentia Pharmaceuticals AB

Completed

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

Allergy

New Zealand
GLWL Research Inc.

Terminated

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01

Diabetes Mellitus, Type 2

United States
Curacle Co., Ltd.

Recruiting

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Diabetic Nephropathies

Korea, Republic of
SymBio Pharmaceuticals

Completed

Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Japan
GlaxoSmithKline

Completed

A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
Avidity Biosciences, Inc.

Completed

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients (MARINA)

Myotonic Dystrophy | Myotonic Disorders | Myotonic Dystrophy Type 1 (DM1) | Myotonic Dystrophy 1 | Myotonic Muscular Dystrophy | DM1 | Dystrophy Myotonic | Steinert Disease

United States
SymBio Pharmaceuticals

Completed

Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Japan
HemaQuest Pharmaceuticals Inc.

Terminated

Effects of HQK-1001 in Patients With Sickle Cell Disease

Sickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin S

United States, Lebanon, Egypt, Canada, Jamaica
HemaQuest Pharmaceuticals Inc.

Completed

Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects

Healthy

United States
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Macular Degeneration

Mexico
GlaxoSmithKline

Completed

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

Asthma

New Zealand
Cerecin
Celerion

Completed

Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

Healthy

United States
MC2 Therapeutics

Completed

Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream

Phototoxicity

United States
AVROBIO

Terminated

Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease

Fabry Disease

United States, Australia, Brazil
RepliCel Life Sciences, Inc.
Syreon Corporation; Innovacell Biotechnologie AG

Terminated

Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)

Tendinopathy | Tendinosis

Canada
Ixchelsis Limited

Completed

A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
Ixchelsis Limited

Completed

A Study of Multiple Oral Doses of IX-01 in Healthy Men

Healthy Participants

United Kingdom
Mitos Pharmaceuticals

Terminated

Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy

Alopecia
Maxinovel Pty., Ltd.

Recruiting

Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

AML

China
Maxinovel Pty., Ltd.

Recruiting

MAX-40279-01 in Patients With Advanced Solid Tumors

Solid Tumor

China
General Practitioners Research Institute
G3 Pharmaceuticals

Enrolling by invitation

G3P-01 in Volunteers With Elevated Galectin-3 (Galaxy)

Healthy Aging | Galectin 3

Netherlands
Hemostemix

Completed

ACP-01 in Patients With Critical Limb Ischemia

Critical Limb Ischemia

United States, Canada
Vedic Lifesciences Pvt. Ltd.

Completed

To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use

Vision Disorders

India
Cali Pharmaceuticals LLC

Completed

Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain

Abdominoplasty

United States
Hepanova Inc.

Unknown

A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

Non-Alcoholic Steatohepatitis (NASH)

United States
Mayo Clinic

Completed

Topical Agent for Treatment of Red Skin

Rosacea | Bilaterally Symmetric Red Skin on Cheeks

United States
Fujifilm Pharmaceuticals U.S.A., Inc.

Recruiting

A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors

Advanced Solid Tumors

United States
Aprea Therapeutics

Not yet recruiting

Study of APR-1051 in Patients With Advanced Solid Tumors (ACESOT-1051)

Advanced Solid Tumor

Search clinical trials for: FF-10501-01

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations